Amundi Eastc Xr Regulatory News (EAST)

13 Jul 2007 08:29

Credit Suisse Securities (Eur) Ltd13 July 2007 PRE-STABILISATION ANNOUNCEMENT Not for distribution, directly or indirectly, in or into the United States orany jurisdiction in which such distribution would be unlawful. EastPharma Ltd 13th July 2007 Pre-Stabilisation Notice Pursuant to Core Dealing Rule 3060-3061, Credit Suisse Securities (Europe)Limited hereby notifies the London Stock Exchange that it and its affiliates maystabilise the offering of the Security below Credit Suisse Securities (Europe) Limited, hereby gives notice that theStabilising Manager(s) named below may stabilise the offer of the followingsecurities in accordance with Commission Regulation (EC) No. 2273/2003implementing the Market Abuse Directive (2003/6/EC). The securities: Issuer: EastPharma Ltd ISIN US27778Q2049 Guarantor (if any): Aggregate nominal amount 15,850,000(Offering): Description: GDR RegS Ratio 1 GDR: 1 Share Offer price: USD 11.00Other offer terms: Stabilisation: Stabilising Manager(s): Credit Suisse Securities (Europe) Limited Contact Indranil Bhattacharyya +44 20 7888 2057 Stabilisation period expected 13th July 2007 at approximately 09:00am London time;to start on: Stabilisation period expected 11th August 2007 (30 days after the proposed issue date of the securities)to end no later than: Over-allotment option 15% of the Offering Existence, maximum size and The Stabilising Manager(s) may over-allot the securities to the extentconditions of use of permitted in accordance with applicable law.over-allotment facility: In connection with the offer of the above securities, the Stabilising Manager(s)may over-allot the securities or effect transactions with a view to supportingthe market price of the securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun,may be ended at any time. Any stabilisation action or over-allotment shall beconducted in accordance with all applicable laws and rules. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of the Issuer in any jurisdiction. This material was produced by Credit Suisse Securities (Europe) Limited, a firmregulated and authorised by The Financial Services Authority (the "FSA"). Thisannouncement and the offer of the securities to which it relates are onlyaddressed to and directed at persons outside the United Kingdom and persons inthe United Kingdom who have professional experience in matters related toinvestments or who are high net worth persons within article 12(5) of theFinancial Services and Markets Act 2000 (Financial Promotion) Order 2005 andmust not be acted on or relied on by other persons in the United Kingdom. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the "Prospectus Directive") beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and theoffer are only addressed to and directed at persons in that Member State who arequalified investors within the meaning of the Prospectus Directive (or who areother persons to whom the offer may lawfully be addressed) and must not be actedon or relied on by other persons in that Member State. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the UnitedStates Securities Act of 1933 and may not be offered or sold in the UnitedStates absent registration or an exemption from registration. There will be nopublic offer of securities in the United States. This information is provided by RNS The company news service from the London Stock Exchange